Printer Friendly

Browse Adjuvant chemotherapy topic

 

Articles

1-189 out of 189 article(s)
Title Author Type Date Words
Genentech Receives Priority Review from US FDA for Perjeta (Pertuzumab) for Adjuvant Treatment of HER2-Positive Early Breast Cancer. Oct 2, 2017 587
United States : FDA grants Priority Review for Roches Perjeta (pertuzumab) for adjuvant treatment of HER2-positive early breast cancer. Sep 30, 2017 306
Transition from Tumor Tissue to Bone Marrow in Patients with Appendicular Osteosarcoma after Neoadjuvant Chemotherapy. Deng, Zhi-Ping; Liu, Bao-Yue; Sun, Yang; Jin, Tao; Li, Bin; Ding, Yi; Niu, Xiao-Hui Report Sep 20, 2017 2331
Puma biotechnology Data from Trial of Neratinib in HER2-Positive Breast Cancer Demonstrates Continued Benefit After 5 years. Sep 11, 2017 439
Predictive models of adjuvant chemotherapy for patients with stage ii colorectal cancer: A retrospective study. Wei, Bo; Zheng, Xiao-Ming; Lei, Pu-Run; Huang, Yong; Zheng, Zong-Heng; Chen, Tu-Feng; Huang, Jiang-L Report Sep 1, 2017 4322
FDA approves new treatment to reduce the risk of breast cancer returning. Jul 17, 2017 635
Updated St. Gallen International Breast Cancer Guidelines Reinforce Important Role of Genomic Testing in Treatment of Early Breast Cancer. Jul 12, 2017 1309
RESPONSE TO NEOADJUVANT CHEMOTHERAPY IN LOCALLY ADVANCED BREAST CANCER ACCORDING TO TUMOR SUBTYPES. Clinical report Jun 30, 2017 3977
Karmanos physician national co-chair in world-wide study; findings could decrease standard treatment for many stage 3 colon cancer patients. Clinical report Jun 7, 2017 908
United States : U.S. women with triple-negative breast cancer treated with neoadjuvant therapy are far more likely to choose mastectomies than women overseas. Jun 3, 2017 428
Lilly Builds Upon Body of Data for Abemaciclib with Phase 3 MONARCH 2 Data Demonstrating Superior Progression-Free Survival in Advanced Breast Cancer. Jun 3, 2017 1934
New research in testicular cancer, ASCO-GU 2017. Hamilton, Robert J.; Kollmansberger, Christian Jun 1, 2017 1261
Paradigm Diagnostics and TME Research Expand Precision Medicine Breast Cancer Registry. May 3, 2017 530
GenomeDx's Decipher Post-Op Demonstrates Positive Impact on Physician, Patient Treatment Decisions in Multicenter Prospective Study. Clinical report Apr 25, 2017 1114
US FDA Advisory Committee to Review Puma Biotechnology's NDA for Neratinib Early Stage Breast Cancer Treatment. Apr 18, 2017 346
Are Oncologists Jumping the Gun with the 21-Gene Assay? Apr 13, 2017 1564
Puma biotechnology Launches Expanded Investigational Therapy Access Programme for US Patients with HER2-Positive Breast Cancer or HER2-Mutated Cancers. Apr 4, 2017 330
Ovarian cancer. Wright, Jason D.; Buskwofie, Ama C. Mar 1, 2017 2913
Focus on treating genital atrophy symptoms. Kaunitz, Andrew M. Jan 1, 2017 1499
Frequency of CYP2D6*10 genotypes in Pakistani breast cancer patients taking adjuvant tamoxifen. Dec 31, 2016 2837
Changes in quality of life among Indian breast cancer patients during adjuvant treatment: a single centre experience. Basu, Abhishek; Basu, Abhijit Report Oct 13, 2016 5260
United States : First Positive Phase 3 Results In Adjuvant Setting For Renal Cell Carcinoma Show SUTENT (sunitinib) Extended Disease Free Survival After Surgical Removal. Oct 12, 2016 506
Cost considerations in determining the affordability of adjuvant trastuzumab in breast cancer. Abratt, R.P. Report Oct 1, 2016 962
Better survival with primary surgery in stage MIC ovarian cancer. Osterweil, Neil Oct 1, 2016 480
A study of adjuvant chemoradiotherapy in resected gastric cancers. Kumari, Chatharaju Swarna; Srikanth, Ranganatharao Report Sep 29, 2016 2594
The biologic behavior of squamous cervical carcinoma after neoadjuvant therapy (NAT) according to immunohistochemical expression of E-cadherin and CD44v6. Gavrilescu, Mihaela Madalina; Balan, Raluca; Scripcariu, Viorel; Ferariu, Dan; Lozneanu, Ludmila; Po Sep 1, 2016 3827
Wilms' tumour in young adult. Arumugam, Senthilvel; Kanakasabapathy, Saravanan; Kannaiyan, Rajesh Report Aug 11, 2016 1702
US FDA receives New Drug Application for Puma Technology's PB272 breast cancer treatment. Jul 25, 2016 175
US FDA receives New Drug Application for Puma Technology's PB272 breast cancer treatment. Jul 25, 2016 171
Intraosseous synovial sarcoma of the calcaneum. Senthil, Vishnu Case study Jul 7, 2016 1063
Complete resection of a primitive neuroectodermal tumour arising in the bladder of a 31-year-old female after neoadjuvant chemotherapy. Lam, Cameron J.; Shayegan, Bobby Report Jul 1, 2016 2126
Puma Biotechnology submits Neratinib MAA as extended adjuvant treatment for HER2-positive early stage breast cancer in Europe. Jun 28, 2016 245
Puma Biotechnology submits Neratinib MAA as extended adjuvant treatment for HER2-positive early stage breast cancer in Europe. Jun 28, 2016 241
GenomeDx's Decipher Platform Utilizes Gene Expression Signatures to Predict Lymph Node Metastasis in Bladder Cancer Patients. Jun 14, 2016 1019
Germany : Bayer collaborates with U.S. National Surgical Adjuvant Breast and Bowel Project (NSABP) to Investigate Stivarga (Regorafenib) as Additional Adjuvant Therapy in Colon Cancer. Jun 2, 2016 391
Bayer Collaborates with U.S. National Surgical Adjuvant Breast and Bowel Project (NSABP) to Investigate Stivarga (Regorafenib) Tablets as Additional Adjuvant Therapy in Colon Cancer. Jun 1, 2016 2695
Sexual dysfunction in premenopausal women treated for breast cancer--implications for their clinical care. Lema, Valentino Manase Report Jun 1, 2016 4474
United Kingdom : Selumetinib granted Orphan Drug Designation in the US for adjuvant treatment of differentiated thyroid cancer. May 13, 2016 376
CLI: The CLIO consortium: Optimization of Cerenkov Luminescence Imaging for Image-Guided Cancer Surgery. Jan 11, 2016 469
Cognitive deficits in breast cancer survivors after chemotherapy and hormonal therapy. Frank, Jennifer Sandson; Vance, David E.; Triebel, Kristen L.; Meneses, Karen M. Report Dec 1, 2015 8517
Japan : Anti-Cancer Agent Xeloda, Obtained Approval for Additional Indication of Postoperative Adjuvant Chemotherapy for Gastric Cancer. Nov 21, 2015 277
Short term outcome and predictors of response to neoadjuvant treatment in rectal cancer. Oct 31, 2015 2335
Predictors of referral for neoadjuvant chemotherapy prior to radical cystectomy for muscle-invasive madder cancer and changes in practice over time. Gotto, Geoffrey T.; Shea-Budgell, Melissa A.; Ruether, Sarah Rose J. Dean Clinical report Aug 1, 2015 4223
Variations in guideline-concordant breast cancer adjuvant therapy in rural Georgia. Guy, Gery P., Jr.; Lipscomb, Joseph; Gillespie, Theresa W.; Goodman, Michael; Richardson, Lisa C.; W Aug 1, 2015 7504
MammaPrint: Improved breast cancer care by innovative diagnostic test MammaPrint. Jul 8, 2015 381
Spontaneous rupture of adult Wilms' tumor: a case report and review of the literature. Huang, Jian-lin; Liao, Yong; An, Yu; Qiu, Ming-xing Clinical report Jul 1, 2015 2489
Seoul National University Hospital Announced Pivotal Study Results Published in Gastroenterology. Jun 8, 2015 836
Neoadjuvant chemotherapy: role in locoregionally advanced oral cancers. Nanda, Manpreet Singh; Mohiyuddin, Azeem Report Jun 1, 2015 4247
Successful neoadjuvant chemotherapy for primary invasive small-cell carcinoma of the ureter. Osaka, Kimito; Kobayashi, Kazuki; Sakai, Naoki; Noguchi, Sumio Clinical report Jun 1, 2015 1529
Phase I Study in Ovarian & Breast Cancer Published in Abstracts of 2015 ASCO Annual Meeting. May 15, 2015 862
Intravesical bacillus Calmette-Guerin versus chemohyperthermia for high-risk non-muscle-invasive bladder cancer. Ekin, Rahmi Gokhan; Akarken, Ilker; Zorlu, Ferruh; Tarhan, Huseyin; Kucuk, Ulku; Yildirim, Zubeyde; Report May 1, 2015 3648
Celsion Expands Clinical Development Plan for GEN-1 IL-12 Immunotherapy Program in Ovarian Cancer. Apr 29, 2015 1469
Primary debulking surgery versus neo-adjuvant chemotherapy in stage III/IV ovarian cancer: Comparison of perioperative morbidity and survival data in Pakistani women. Mar 31, 2015 2711
SOFT endorses selective ovarian suppression. Jancin, Bruce Jan 1, 2015 1034
Systematic review: adjuvant chemotherapy for locally advanced rectal cancer with respect to stage of disease. Hajibandeh, Shahab; Hajibandeh, Shahin Clinical report Jan 1, 2015 6750
High risk stage 2 and stage 3 colon cancer, predictors of recurrence and effect of adjuvant therapy in a nonselected population. van Eeghen, Elmer E.; Bakker, Sandra D.; van Bochove, Aart; Loffeld, Ruud J.L.F. Jan 1, 2015 6193
Halaven (Eribulin) in Combination with Capecitabine Provides Clinical Benefit for Women with Metastatic Breast Cancer. Dec 9, 2014 2687
Patterns of care and outcomes of adult osteosarcoma in a tertiary care cancer centre in Pakistan. Oct 31, 2014 2974
United Kingdom : GSK announces Phase III ALTTO results for anti-HER2 therapy combination in the adjuvant breast cancer treatment setting. Jun 3, 2014 371
Impact of sequential neoadjuvant chemotherapy in locally advanced breast cancer: a series of 10 cases. Ghosh, Gopa; Jain, Megha; Samaiya, Atul; Gaur, Bindu Apr 28, 2014 2244
Agendia presents new positive findings for MammaPrint, BluePrint breast cancer tests. Mar 26, 2014 311
Bayer and Onyx Report Phase 3 Study Results of NEXAVAR (sorafenib) as Adjuvant Treatment for Patients with Liver Cancer Who Have Undergone Surgery or Local Ablation. Clinical report Mar 11, 2014 3213
Improving the outcome of patients with muscle invasive urothelial carcinoma of the bladder with neoadjuvant gemcitabine/cisplatin chemotherapy: A single institution experience. El-Gehani, Faraj; North, Scott; Ghosh, Sunita; Venner, Peter Report Mar 1, 2014 4454
Uptake of neoadjuvant chemotherapy for invasive bladder cancer. Kassouf, Wassim Report Mar 1, 2014 1601
Re: The feasibility of radical cystectomy in elderly patients. Editorial Mar 1, 2014 1041
Bisphosphonate of no help in chemoresistant breast ca. Jancin, Bruce Feb 1, 2014 491
Partial cystectomy after neoadjuvant chemotherapy: Memorial Sloan Kettering Cancer Center contemporary experience. Bazzi, Wassim M.; Kopp, Ryan P.; Donahue, Timothy F.; Bernstein, Melanie; Russo, Paul; Bochner, Bern Report Jan 1, 2014 3642
Novel treatments utilize standard drugs to double "high value" response rates for patients with resistant ovarian cancer. Oct 10, 2013 653
Galena Biopharma participates at the American College of Surgeons Clinical Congress 2013. Oct 7, 2013 224
Racial/ethnic differences in receipt of timely adjuvant therapy for older women with breast cancer: are delays influenced by the hospitals where patients obtain surgical care? Freedman, Rachel A.; He, Yulei; Winer, Eric P.; Keating, Nancy L. Oct 1, 2013 5559
Naturopathic co-management of patients receiving adjuvant endocrine therapy for breast cancer. Dunn, Stacy Report Aug 1, 2013 2628
Pathologic response and long-term follow-up in breast cancer patients treated with neoadjuvant chemotherapy: a comparison between classifications and their practical application. Corben, Adriana D.; Abi-Raad, Rita; Popa, Ion; Teo, Clarence H.Y.; Macklin, Eric A.; Koerner, Freder Report Aug 1, 2013 6742
The influence of adjuvant radiotherapy on ovarian function, menopausal symptoms and quality of sexual life in cervical cancer patients. Berza, Natalija; Vitols, Jurgis; Vitols, Juris; Reinis, Aigars; Skadins, Ingus; Macuks, Ronalds Clinical report Jun 1, 2013 2846
Spindle cell sarcoma of vagina--a case report. Sankareswari, R.; Geetha, K.; Vani, S.; Divya, M. Clinical report Apr 29, 2013 1590
Uncaria tomentosa-adjuvant treatment for breast cancer: clinical trial. Brief article Apr 1, 2013 154
War on cancer: Hyperthermia's success in treating rectal cancer. Moss, Ralph Report Jan 1, 2013 2522
Natural history of pT3-4 or node positive bladder cancer treated with radical cystectomy and no neoadjuvant chemotherapy in a contemporary North-American multi-institutional cohort. Power, Nicholas E.; Kassouf, Wassim; Bell, David; Aprikian, Armen G.; Fradet, Yves; Lacombe, Louis; Report Dec 1, 2012 3981
AstraZeneca Begins a New Global Study of FASLODEX (Fulvestrant) 500 mg Injection in Patients With Hormone Receptor-Positive Advanced Breast Cancer. Oct 29, 2012 1842
United States : Adjuvant Chemotherapy Does Not Increase Risk of Acute Myeloid Leukemia and Myelodysplastic Syndrome. Clinical report Sep 15, 2012 391
Two synchronous non small cell lung carcinomas with different morphologies in the same lobe. Boulemden, A.; Webb, E.; Muller, S.; Nakas, A.; Rathinam, S. Case study Aug 1, 2012 1063
Quinary debulking for epithelial ovarian cancer. Edwards, James M.; Lowery, William Jeffrey; Secord, Angeles Alvarez Case study Jul 1, 2012 1392
Scientists use PET to predict increased survival in cancer patients. Jun 1, 2012 129
Diagnosing breast cancer: an opportunity for innovative engineering. Vaughan, Christopher L.; Evans, Michael D. Report Jun 1, 2012 2620
Urinary bladder carcinosarcoma: a complete pathological response after neoadjuvant chemotherapy: Mesane karsinosarkomu: Neoadjuvan kemoterapi sonrasi tam patolojik yanit. Tazi, Fadl Mohammed; Ahallal, Youness; Benlemlih, Amal; Khallouk, Abdelhak; Elfassi, Mohammed Jamal; Jun 1, 2012 1342
Breast MRI 'better than clinical approach for predicting chemotherapy's efficiency'. May 23, 2012 441
Cancer Therapeutics' First Product Achieves Preclinical Proof of Concept. Apr 3, 2012 559
Location, location, location: prostate biopsies and MRIs. Klotz, Laurence H. Editorial Apr 1, 2012 750
Recurrent transitional cell carcinoma of the bladder: A mixed nested variant case report and literature review. De Berardinis, Ettore; Busetto, Gian Maria; Giovannone, Riccardo; Antonini, Gabriele; Di Placido, Ma Clinical report Apr 1, 2012 2373
First-Ever Prospective Diagnostic Study in Breast Cancer. Clinical report Mar 22, 2012 866
Aorto-conduit fistula developing four years after esophagectomy. Strong, S.; Higgs, S.; Streets, C.; Titcomb, D.; Barham, P.; Blazeby, J.; Hollowood, A. Case study Feb 1, 2012 983
Myxoid/round cell liposarcoma of the supraclavicular fossa. Oysu, Cagatay; Uslu, Celil; Naiboglu, Baris; Ogredik, Evren Ay Case study Feb 1, 2012 1453
Targeted therapies in breast cancer: tailoring treatment to the molecular drivers of disease progression. Hicks, David G. Report Jan 1, 2012 1911
Effect of community population size on breast cancer screening, stage distribution, treatment use and outcomes. Olson, Robert A.; Nichol, Alan; Caron, Nadine R.; Olivotto, Ivo A.; Speers, Caroline; Chia, Stephen; Report Jan 1, 2012 4655
Assessing treatment effect in pancreatic cancer. Hartman, Douglas J.; Krasinskas, Alyssa M. Disease/Disorder overview Jan 1, 2012 6555
Roche's Genentech, Galena to partner on combined breast cancer therapy. Nov 28, 2011 230
Dendreon Begins Enrollment in Phase 2 Neu-ACT Trial for Second Active Cellular Immunotherapy Product Candidate, DN24-02. Oct 17, 2011 885
Options and limitations of ductal pancreatic cancer treatment. Seufferlein, Thomas Report Oct 15, 2011 406
Mistletoe therapy in adjuvant and palliative therapy of pancreatic carcinoma: concepts-facts-perspectives. Matthes, H.; Buchwald, D.; Schad, F. Report Oct 15, 2011 557
Viscum album fermentatum Pini versus oral Etoposide as adjuvant treatment in osteosarcoma patients after second relapse. Longhi, A.; Mariani, E.; Kuehn, J.; Reif, M. Report Oct 15, 2011 450
Primary mucosal desmoplastic melanoma of the nasal vestibule: the second case. Cervantes, Sergio S.; Baugh, Reginald Case study Oct 1, 2011 1997
Chemotherapy 'equally effective before and after breast cancer surgery'. Sep 9, 2011 302
Breast cancer: prevention, detection targeting molecular markers. Jurasunas, Serge Report Aug 1, 2011 4585
A study of pathologic risk factors in postchemoreduced, enucleated specimens of advanced retinoblastomas in a developing country. Suryawanshi, Pallavi; Ramadwar, Mukta; Dikshit, Rajesh; Kane, Shubhada V.; Kurkure, Purna; Banavali, Report Aug 1, 2011 4366
Rosetta Genomics and UC Davis Researchers to Develop and Validate microRNA Biomarker to Predict Response to Neoadjuvant Chemotherapy in Bladder Cancer. Clinical report Jun 28, 2011 1866
BSD Medical Announces Hyperthermia Presentations at 2011 ASCO Meeting. Jun 14, 2011 790
Breast Cancer Genomic Test Shown to Predict Patient Survival Following Adjuvant Chemotherapy. Jun 3, 2011 678
CCO Presents Results of Clinician Utilization of Online Decision Support Tool Presented as Part of 2011 ASCO Annual Meeting in Chicago. Jun 3, 2011 697
Reliability of a health questionnaire among women with brain injury. Colantonio, Angela; Harris, Jocelyn E.; Tarek, Nisanne Report Jun 1, 2011 5659
Malignant mixed mullerian tumor in two patients receiving tamoxifen therapy. Koukouliata, A. Report Jun 1, 2011 1725
Adjuvant chemotherapy with lomustine in the treatment of grade III canine mastocytoma--report of two cases/Quimioterapia adjuvante com lomustina no tratamento do mastocitoma canino de grau III--relato de dois casos/Quimioterapia adyuvante con lomustina en el tratamiento del mastocitoma canino del grado III--relato de dos casos. Horta, Rodrigo dos Santos; Lavalle, Gleidice Eunice; Rodrigues, Antonio Augusto Munhoz; de Campos, C Jun 1, 2011 1657
Sarcomatous carcinoma with osteosarcomatoid differentiation of the bladder with simultaneous sigmoid colon adenocarcinoma. Atilgan, D.; Parlaktas, B.S.; Uluocak, N.; Erdemir, F. Case study May 14, 2011 949
Wider role for neoadjuvant chemo in ovarian cancer. McNamara, Damian May 1, 2011 645
Uveal tract melanoma: referral refinement part 1 course code: C-15795 O/D. Cohen, Victoria; Papastefanou, Vasilios P. Disease/Disorder overview Apr 8, 2011 2906
A tailored occupational therapy approach to cognitive rehabilitation of chemotherapy-related cognitive side effects in breast cancer survivors: two case studies of premenopausally affected women. Ryan, Elizabeth L.; Miskovitz, Gabrielle; Sutton, Desmond; Ahles, Tim Report Mar 1, 2011 12728
Rehabilitation of therapy-related cognitive deficits in patients with breast cancer. Weis, Joachim; Poppelreuter, Martin; Bartsch, Hans Helge Report Mar 1, 2011 5868
Axillary lymph node dissection confers no survival advantage. Moon, Mary Ann Mar 1, 2011 819
Genomic profile predicts colon cancer recurrence risk. London, Susan Clinical report Mar 1, 2011 249
Axillary lymph node dissection: no clear benefit. Moon, Mary Ann Mar 1, 2011 894
Surgical treatment of pancreatic cancer. Conway, W. Charles, II; Bolton, John S. Disease/Disorder overview Mar 1, 2011 4396
A biobehavioral perspective on depressive symptoms in patients with cerebral astrocytoma. Starkweather, Angela R.; Sherwood, Paula; Lyon, Debra E.; McCain, Nancy L.; Bovbjerg, Dana H.; Broad Clinical report Feb 1, 2011 7872
NewLink Genetics to Present Phase 2 Data of Its HyperAcute Pancreas Immunotherapy at ASCO 2011 Gastrointestinal Cancers Symposium. Jan 21, 2011 1085
Quality of life in breast cancer patients during chemotherapy and concurrent therapy with a mistletoe extract. Eisenbraun, J.; Scheer, R.; Kroz, M.; Schad, F.; Huber, R. Clinical report Jan 15, 2011 6870
Zoledronic acid flops in breast cancer trial. Wachter, Kerri Jan 1, 2011 604
Clinical outcome of adjuvant endocrine treatment according to Her-2/neu status in breast cancer. James, Rani; K., Thriveni; Krishnamoorthy, Lakshmi; Deshmane, Vijayalaxmi; P.P., Bapsy; Ramaswamy, G Report Jan 1, 2011 3613
Should screening for tamoxifen metabolism be routine? Coombes, R. Charles; Rose, Carsten Jan 1, 2011 1226
More Node Negative Patients Surviving Breast Cancer: Findings Reported at 2010 San Antonio Breast Cancer Symposium. Clinical report Dec 11, 2010 1422
Novelos Therapeutics Announces Presentation of Positive Phase 2 Results in NOV-002 Neoadjuvant Breast Cancer Trial at San Antonio Breast Cancer Symposium. Financial report Dec 9, 2010 1515
Why all prostate cancer surgery should include an adequate lymph node dissection. Siemens, D. Robert Report Dec 1, 2010 2490
Anastrozole tops tamoxifen in analysis of ATAC trial. Splete, Heidi Dec 1, 2010 840
Non-surgical management of the axilla. Crowley, Clare Dec 1, 2010 3199
Study Shows BSGI/MBI is More Accurate in Establishing Tumor Size After Neoadjuvant Chemotherapy in Patients With Breast Cancer Than Other Imaging Modalities. Nov 4, 2010 484
Journal abstracts: is it the time for metformin to take place in adjuvant treatment of Her-2 positive breast cancer? Teaching new tricks to old dogs. Brief article Nov 1, 2010 188
Try aromatase inhibitor for subset of breast Ca. Moon, Mary Ann Oct 1, 2010 900
An ObGyn's guide to aromatase inhibitors as adjuvant therapy for breast CA: you may not prescribe anastrozole, letrozole, or exemestane, but there's a strong possibility that some of your patients are taking one of these medications. Here's what you need to know to encourage compliance and ease their ill effects. Yates, Janelle Oct 1, 2010 4443
Referral and treatment rates of neoadjuvant chemotherapy in muscle-invasive bladder cancer before and after publication of a clinical practice guideline. Miles, Brendan J.W.; Fairey, Adrian S.; Eliasziw, Michael; Estey, Eric P.; Venner, Peter; Finch, Day Report Aug 1, 2010 2818
Using clinical practice guidelines in our own backyard: treating our patients with bladder cancer. Black, Peter Report Aug 1, 2010 783
BSD Medical Announces Presentation at ASCO of Duke University Clinical Study Using Hyperthermia with Chemotherapy to Treat Bladder Cancer. Clinical report Jul 15, 2010 1016
Breast Ca patients respond to neoadjuvant HT. London, Susan Jul 1, 2010 840
Active surveillance not yet standard. Thrasher, J. Brantley Brief article Jul 1, 2010 272
Aromatase inhibitors and bone health. Bundred, Nigel J. Clinical report Jul 1, 2010 4209
Fertility issues following breast cancer treatment. Jones, Alison Clinical report Jul 1, 2010 2869
Cardiac health following drug treatment for breast cancer. Verrill, Mark Jul 1, 2010 3407
The psychosocial issues of survivorship in breast cancer. Maher, Jane; Fenlon, Deborah Clinical report Jul 1, 2010 5804
Tumour markers in oral neoplasia. Sanjay, Reddy B.; Madhavi, Reddy B.; Shyam, N.D.V.N. Report Jan 1, 2010 6961
New techniques and their implications. Stebbing, Justin Guest editorial Dec 1, 2009 630
Histopathologic risk factors in retinoblastoma in India. Gupta, Roshmi; Vemuganti, Geeta K.; Reddy, Vijay Anand P.; Honavar, Santosh G. Report Aug 1, 2009 3337
How can we treat elderly patients with colorectal cancer? Rougier, Philippe; Cudennec, Tristan; Mitry, Emmanuel Report Mar 1, 2009 1771
Deterioro cognitivo inducido por los tratamientos oncologicos sistemicos en el cancer de mama no metastatico: revision de estudios. Rubio, Beatriz; Sirgo, Agustina; Forcadell, Eva; Mele, Mireia; Guma, Josep Report Jan 1, 2009 19014
The influence of hormonal therapy on the cognitive functioning of postmenopausal breast cancer patients. Schilder, Christien M.T.; Schagen, Sanne B. Clinical report Dec 1, 2008 3177
Adjuvant treatment for radically resected gastric cancer patients: the vexata quaestio. Galizia, Eva; Scartozzi, Mario; Berardi, Rossana; Pistelli, Mirco; Bittoni, Alessandro; Cascinu, Ste Dec 1, 2008 4405
Chemotherapy beneficial in BRCA1/2 carriers. MacNeil, Jane Salodof Clinical report Nov 1, 2008 555
Breast cancer. Edge, Jenny Report Oct 1, 2008 344
Breast cancer treatment is one of the success stories of our time. Boeddinghaus, Irene Report Oct 1, 2008 2196
Perioperative management of gastro-oesophageal cancer. Petkar, Imran; Okines, Alicia Report Sep 1, 2008 3716
In a study of women with axillary lymph node-positive or high-risk, lymph node-negative breast cancer, treatment with paclitaxel every week rather than every 3 weeks following adjuvant chemotherapy improved both overall and disease-free survival. Brief article Apr 21, 2008 175
30th Annual San Antonio Breast Cancer Symposium. Parton, Marina Mar 1, 2008 3392
The role of biomarkers in breast cancer. Murrary, Nick Editorial Dec 1, 2007 1282
Predicting chemosensitivity and resistance in breast cancer. Bartlett, John M.S.; Faratian, Dana Clinical report Dec 1, 2007 3749
Phase II study of preoperative sequential FEC and docetaxel predicts of pathological response and disease free survival. Barrett-Lee, Peter Clinical report Dec 1, 2007 467
Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial. Carrato, Alfredo; Guillen-Ponce, Carmen Clinical report Dec 1, 2007 1188
Western diet linked to colon cancer return. Moon, Mary Ann Nov 1, 2007 359
What is the next step for adjuvant breast cancer chemotherapy following integration of taxanes into established anthracycline-based regimens? Nolan, Luke; Murray, Nick Clinical report Sep 1, 2007 3522
Long-term survival of a patient with primarily unresectable liver metastasis from rectal cancer after neoadjuvant chemotherapy. Sprenger, Katharina; Folprecht, Gunnar Sep 1, 2007 1702
Initial versus sequential adjuvant aromatase inhibitor therapy: a review of the current data. Wardley, Andrew Jun 1, 2007 530
Actualizacion del tratamiento adyuvante en cancer de mama. Puente, Javier; Martin, Miguel Report Jan 1, 2007 10374
Anthracycline Chemo tied to HF in older women. Lowry, Fran Clinical report Aug 15, 2006 246
Survival not better with chemo for early NSCLC. MacNeil, Jane Salodof Aug 1, 2006 637
Analisis del proceso de enfermedad: variables medicas y psicologicas en una muestra de pacientes con cancer de mama. Moreno, Pilar; Almonacid, Vicenta; Queipo, Silvia; Lluch, Ana Disease/Disorder overview Jan 1, 2006 4509
Cancer de pulmon no microcitico: quimioterapia y otros tratamientos sistemicos. Rodriguez-Lajusticia, Laura; Villalobos, Maria Laura; Garcia-Paredes, Beatriz; Puente Vazquez, Javie Report Jan 1, 2006 9535
Late stage (III and IV) non-small cell cancer of the lung: results of surgical resection at Inova Fairfax Hospital. Graling, Paula Nov 1, 2005 4986
Guideline: use aromatase inhibitor as adjuvant Tx. Mahoney, Diana Jun 15, 2005 1063
Options updated for adjuvant colon cancer Tx. Mahoney, Diana May 15, 2005 742
Anastrozole deemed cost effective as adjuvant therapy. Jancin, Bruce Brief Article Feb 1, 2005 221
Adjuvant chemo best in ER-negative tumors. Jancin, Bruce Feb 1, 2005 593
New approaches boost survival in lung cancer: ASCO roundup. Mahoney, Diana Aug 15, 2003 1645
New approaches boost lung cancer survival rates; early stage, locally advanced, recurrent. Mahoney, Diana Aug 1, 2003 1641
Mistletoe improves tolerability of breast cancer treatment. (Multicenter Cohort Study). Walsh, Nancy Brief Article Feb 1, 2003 231
Adjuvant bisphosphonate reduces bone metastases. (In Breast Cancer Patients). Jancin, Bruce Feb 15, 2002 330
Anastrozole bests tamoxifen in early breast cancer trial: A 17% drop in risk of disease recurrence was seen in postmenopausal patients. (ATAC Study of 9,366 Women). Jancin, Bruce Product/Service Evaluation Jan 15, 2002 682
Conquering Cancer: An Alternate View - Emotions on the Defense Team. Dees, Craig Brief Article Jul 1, 2001 208
Tamoxifen Not for Receptor-Negative Breast Ca. FINN, ROBERT Jul 1, 2001 383
Adjuvan Tamozxifen Benefits Persist for 15 Years. WORCESTER, SHARON Brief Article Jun 1, 2001 268
System Failure Hampers Care For Breast Ca. JOHNSON, KATE Jul 1, 2000 417
More Exercise May Be Answer to Chemotherapy Weight Gain. MOON, MARY ANN Brief Article May 1, 2000 376
Biomarkers May Spare Early Breast Cancer Patients Adjuvant Therapy. JANCIN, BRUCE Mar 15, 2000 487
Biomarkers May Spare Early Breast Cancer Patients Adjuvant Therapy. Brief Article Feb 1, 2000 583
AUA Panel Releases Treatment Guidelines for Bladder Cancer. Feb 1, 2000 380
Practice setting and physician influences on judgments of colon cancer treatment by community physicians. McFall, Stephanie L.; Warnecke, Richard B.; Kaluzny, Arnold D.; Ford, Leslie Apr 1, 1996 4777
Spare node-negative cancer patients complex therapy. Jan 1, 1991 451

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters